Synapse

← ABC Heart Failure & Cardiomyopathy

Papers in ABC Heart Failure & Cardiomyopathy

Page 3 · newest first

  1. Cardiovascular Diseases in Oncological Patients Treated at a Tertiary Hospital in the Northern Macroregion of Rio Grande do SulABC Heart Failure & Cardiomyopathy · 2023
  2. Correlation between Pulse Pressure and Sub-maximal Functional Capacity in Patients with Heart Failure with Preserved Ejection FractionABC Heart Failure & Cardiomyopathy · 2023
  3. Is Salt Restriction Really Necessary in Patients with Acute Decompensated Heart Failure?ABC Heart Failure & Cardiomyopathy · 2023
  4. Genetics in Cardiomyopathies – Genetic Tests Decoded for the Clinical CardiologistABC Heart Failure & Cardiomyopathy · 2023
  5. How to Change the Medical History of Patients with Heart Failure and Recurrent Hospitalizations?ABC Heart Failure & Cardiomyopathy · 2023
  6. Evolution of Hematological Parameters in Patients with Vasoplegia Following Coronary Artery Bypass Graft SurgeryABC Heart Failure & Cardiomyopathy · 2023
  7. Peculiarities in the Treatment of Cardiomyopathy Associated with High-Output ConditionsABC Heart Failure & Cardiomyopathy · 2023
  8. Hypertonic Saline Solution: How, Why, and for Whom?ABC Heart Failure & Cardiomyopathy · 2023
  9. Treating Diuretic Resistance in Light of New EvidenceABC Heart Failure & Cardiomyopathy · 2023
  10. Point-of-Care Ultrasound in Acute Heart Failure: Basic Concepts for Clinical PracticeABC Heart Failure & Cardiomyopathy · 2023
  11. Brazilian Scientific Production about Cardiomyopathies: A Review from 2010 to 2022ABC Heart Failure & Cardiomyopathy · 2023
  12. P-Wave Indices for Risk Assessment of Atrial Fibrillation in Chagas DiseaseABC Heart Failure & Cardiomyopathy · 2023
  13. How Can Biomarkers Be Useful in the Management of Acute Heart Failure?ABC Heart Failure & Cardiomyopathy · 2023
  14. Surgical Treatment of CardiomyopathyABC Heart Failure & Cardiomyopathy · 2023
  15. Circulatory Support Devices in Acute Heart Failure: Which and When?ABC Heart Failure & Cardiomyopathy · 2023
  16. Evaluation the In Vitro Action of Ciprofloxacin Hydrochloride, Naproxen, and Folic Acid on Trypanosoma cruzi, using Benznidazole as a Gold StandardABC Heart Failure & Cardiomyopathy · 2023
  17. Obstructive Cardiac TumorsABC Heart Failure & Cardiomyopathy · 2022
  18. Dobutamine vs Milrinone in Heart Failure with Preserved Ejection Fraction: How do We Choose?ABC Heart Failure & Cardiomyopathy · 2022
  19. Invasive Hemodynamic Monitoring in the Diagnosis of Heart Failure with Preserved Ejection FractionABC Heart Failure & Cardiomyopathy · 2022
  20. Essential Therapy for Heart Failure with Preserved Ejection Fraction in 2022ABC Heart Failure & Cardiomyopathy · 2022
  21. Flowchart for Treatment of Heart Failure with Preserved Ejection FractionABC Heart Failure & Cardiomyopathy · 2022
  22. Left Atrial Cardiomyopathy as a Generator of Heart Failure with Preserved Ejection FractionABC Heart Failure & Cardiomyopathy · 2022
  23. Treatment of Heart Failure with reduced Ejection Fraction in 2022: The Essential PillarsABC Heart Failure & Cardiomyopathy · 2022
  24. Pharmacological Treatment in Patients with Advanced Heart Failure: Recommendations and ChallengesABC Heart Failure & Cardiomyopathy · 2022
  25. Association of Age with Optimal Medical Therapy in Patients with Chronic Heart FailureABC Heart Failure & Cardiomyopathy · 2022
  26. Heart Failure with Improved Ejection FractionABC Heart Failure & Cardiomyopathy · 2022
  27. Diagnostic Scores in Heart Failure with Preserved Ejection FractionABC Heart Failure & Cardiomyopathy · 2022
  28. I NEED HELP: How to Indentify Patients with Advanced Cardiac Dysfunction?ABC Heart Failure & Cardiomyopathy · 2022
  29. Diuretics in Treatment of Heart FailureABC Heart Failure & Cardiomyopathy · 2022
  30. Personalized Treatment of Heart Failure with Reduced Ejection Fraction: Ivabradine, Nitrate/Hydralazine, and Digoxin – A Systematic Review and Meta-AnalysisABC Heart Failure & Cardiomyopathy · 2022
  31. Echocardiography in Heart Failure with Preserved Ejection Fraction: From Primary Care to Tertiary HospitalsABC Heart Failure & Cardiomyopathy · 2022
  32. Physical Training in Heart Failure with Preserved Ejection FractionABC Heart Failure & Cardiomyopathy · 2022
  33. Myocarditis: Whole Heart Involvement Revealed by Cardiac Magnetic Resonance Mapping. A Case-control StudyABC Heart Failure & Cardiomyopathy · 2022
  34. Sequencing of Pharmacotherapy for Heart Failure with Reduced Ejection Fraction: A Clinical Profile-Based ApproachABC Heart Failure & Cardiomyopathy · 2022
  35. Efficacy of Different Cumulative Doses of Doxorubicin in the Induction of a Dilated Cardiomyopathy Model in RatsABC Heart Failure & Cardiomyopathy · 2022
  36. Treatment of Heart Failure Based on Natriuretic Peptide Levels: A Question That Has Yet to be Solved?ABC Heart Failure & Cardiomyopathy · 2022
  37. Invasive Cardiopulmonary Hemodynamic Assessment in Patients with Advanced Heart Failure: How to Interpret?ABC Heart Failure & Cardiomyopathy · 2022
  38. Asymptomatic Ventricular Dysfunction and HFrEF Secondary to Classic ChemotherapyABC Heart Failure & Cardiomyopathy · 2022
  39. Pharmacological Primary Prevention of Chemotherapy-Induced Cardiomyopathy: What is the Best Approach?ABC Heart Failure & Cardiomyopathy · 2022
  40. Treatment Strategies for Refractory CongestionABC Heart Failure & Cardiomyopathy · 2022
  41. Rethinking the Definition of Heart Failure Based on Ejection Fraction: Reflections with Impact on TherapyABC Heart Failure & Cardiomyopathy · 2022
  42. Advanced Heart Failure in the Cancer PatientABC Heart Failure & Cardiomyopathy · 2022
  43. Implementation of Home Use of Continuous Intravenous Inotrope as Palliative Therapy for a Patient with Advanced Heart Failure within the Brazilian Unified Health System: a Case ReportABC Heart Failure & Cardiomyopathy · 2022
  44. HFREF Pharmacological Treatment Sequencing: The Traditional ApproachABC Heart Failure & Cardiomyopathy · 2022
  45. Pericardial Disease in Patients with CancerABC Heart Failure & Cardiomyopathy · 2022
  46. Diagnosis of Heart Failure with Preserved Heart Failure in the Office Setting: How to Assemble this Puzzle?ABC Heart Failure & Cardiomyopathy · 2022
  47. The Role of Biomarkers in Heart Failure with Preserved Ejection FractionABC Heart Failure & Cardiomyopathy · 2022
  48. Cardio-Protection Against Cancer Treatment-Related Cardiac Dysfunction: Who is at Risk?ABC Heart Failure & Cardiomyopathy · 2022
  49. Hypertension in Patients with Cancer as a Predictor of Ventricular DysfunctionABC Heart Failure & Cardiomyopathy · 2022
  50. Pharmacokinetics, Mechanism of Action, and Adverse Effects of the Main Drugs Used to Treat Heart Failure: A Practical Overview for the Clinical CardiologistABC Heart Failure & Cardiomyopathy · 2022